{
    "clinical_study": {
        "@rank": "112640", 
        "arm_group": [
            {
                "arm_group_label": "Bee Venom Acupuncture", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Loxoprofen", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "EWCT : Bee Venom Acupucture and Loxoprofen", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the efficacy and safety of east-west collaborative\n      treatment using bee venom acupuncture and NSAIDs on pain intensity, functional status and\n      quality of life of patients with chronic cervicalgia"
        }, 
        "brief_title": "East-West Collaboration Treatment Using Bee Venom Acupuncture and NSAIDs for Chronic Cervicalgia", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Non-specific, Uncomplicated Neck Pain", 
        "condition_browse": {
            "mesh_term": "Neck Pain"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age between 18 and 65 years\n\n          -  nonspecific, uncomplicated, chronic neck pain over 3 months\n\n          -  volunteer can read and write in Korean, providing written informed consent\n\n        Exclusion Criteria:\n\n          -  exhibited abnormalities on neurological examination\n\n          -  radicular pain\n\n          -  serious spinal disorders including malignancy, vertebral fracture, spinal infection\n             or inflammatory spondylitis\n\n          -  other chronic diseases that could affect or interfere with the therapeutic outcomes\n             including cardiovascular disease, diabetic neuropathy, active hepatitis,\n             fibromyalgia, rheumatoid arthritis, dementia or epilepsy\n\n          -  previous spinal surgery or scheduled procedures during the study\n\n          -  painful conditions induced by traffic accidents\n\n          -  a substantial musculoskeletal problem generating pain from an area other than the\n             neck\n\n          -  conditions for which administration of BVA might not be safe including clotting\n             disorders, administration of an anticoagulant agent, pregnancy and seizure disorders\n\n          -  a documented hypersensitive reaction to previous BVA treatments, bee stings or insect\n             bites\n\n          -  positive reaction observed during a skin hypersensitivity test\n\n          -  severe psychiatric or psychological disorders\n\n          -  current use of corticosteroids, narcotics, muscle relaxants or herbal medicines to\n             treat neck pain or any medication considered inappropriate by the investigator\n\n          -  pending lawsuits or receipt of compensation due to neck pain."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01922466", 
            "org_study_id": "KHNMC-OH-IRB 2012-019"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Bee Venom Acupuncture", 
                    "EWCT : Bee Venom Acupucture and Loxoprofen"
                ], 
                "description": "Bee Venom 1:20,000 under BVA Increment Protocol\n- Increment Protocol as\n1st week - SC 0.2cc/day, 2 days/week\n2nd week - SC 0.4cc/day, 2 days/week\n3nd week - SC 0.8cc/day, 2 days/week", 
                "intervention_name": "Bee Venom Acupuncture", 
                "intervention_type": "Procedure", 
                "other_name": "pharmacopuncture"
            }, 
            {
                "arm_group_label": [
                    "Loxoprofen", 
                    "EWCT : Bee Venom Acupucture and Loxoprofen"
                ], 
                "description": "60 mg/Tab, pers os 1Tab tid, for 3 weeks", 
                "intervention_name": "Loxoprofen", 
                "intervention_type": "Drug", 
                "other_name": "Loxonin"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Inflammatory Agents, Non-Steroidal", 
                "Loxoprofen"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "chronic neck pain", 
            "combined treatment between conventional and complementary alternative medical treatment", 
            "bee venom acupuncture", 
            "NSAIDs"
        ], 
        "lastchanged_date": "February 13, 2014", 
        "location": {
            "contact": {
                "email": "seohbk@hanmail.net", 
                "last_name": "Byung-Kwan Seo, PhD., KMD", 
                "phone": "82-2-440-7482"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "134-727"
                }, 
                "name": "Spine Center, Kyung Hee University Hospital at Gangdong"
            }, 
            "investigator": {
                "last_name": "Byung-Kwan Seo, PhD., KMD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "3", 
        "official_title": "Clinical Research on the Efficacy and Safety of East-West Collaborative Treatment Using NSAIDs and BV on Chronic Cervical Pain; A Randomized, Controlled, Parallel, Pilot Study", 
        "other_outcome": {
            "measure": "Skin Roll Test", 
            "safety_issue": "No", 
            "time_frame": "Changes from baseline in skinfold thickness and pressure algometer scores at 4th and 8th week follow-up"
        }, 
        "overall_contact": {
            "email": "seohbk@hanmail.net", 
            "last_name": "Byung-Kwan Seo, PhD, KMD", 
            "phone": "82-2-440-7482"
        }, 
        "overall_official": {
            "affiliation": "Kyung Hee University", 
            "last_name": "Byung-Kwan Seo, PhD., KMD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Visual Analogue Scale for bothersomeness", 
            "safety_issue": "No", 
            "time_frame": "Changes from baseline in VAS at 1st, 2nd, 3rd, 4th and 8th week follow-up"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01922466"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Kyunghee University Medical Center", 
            "investigator_full_name": "Byung-Kwan Seo", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Neck Disability Index", 
                "safety_issue": "No", 
                "time_frame": "Changes from baseline in NDI at 2nd, 3rd, 4th and 8th week follow-up"
            }, 
            {
                "measure": "Depression scores on Beck's Depression Inventory", 
                "safety_issue": "No", 
                "time_frame": "Changes from baseline in BDI at 4th and 8th week follow-up"
            }, 
            {
                "measure": "Quality of Life scores on EQ-5D", 
                "safety_issue": "No", 
                "time_frame": "Changes from baseline in EQ-5D at 2nd, 3rd, 4th and 8th week follow-up"
            }, 
            {
                "measure": "Quality of Life scores on SF-36", 
                "safety_issue": "No", 
                "time_frame": "Changes from baseline in SF-36 at 4th and 8th week follow-up"
            }, 
            {
                "measure": "Visual Analogue Scale for pain intensity", 
                "safety_issue": "No", 
                "time_frame": "Changes from baseline in VAS at 1st, 2nd, 3rd, 4th and 8th week follow-up"
            }, 
            {
                "description": "Any adverse events must be documented and reported.", 
                "measure": "Safety profile", 
                "safety_issue": "Yes", 
                "time_frame": "At every visit, up to 2 months"
            }, 
            {
                "measure": "Credibility test", 
                "safety_issue": "No", 
                "time_frame": "Changes from baseline in credibility test at 4th week follow-up"
            }
        ], 
        "source": "Kyunghee University Medical Center", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Kyung Hee University Gangdong Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Kyung Hee University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Korea Institute of Oriental Medicine", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Kyunghee University Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}